1560 TRAPELO ROAD, WALTHAM, MA
Market cap: $2.8B (2/09/2026)
Price: $17.14
Investor Presentation
Vikram Karnani Elected as Class II Director of Dyne Therapeutics
Announces Pricing of Upsized $350.0 Million Public Offering of Common Stock
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Earnings Release
Changes in Board, Management or Compensation
Announces FDA Breakthrough Therapy Designation for DYNE-251 in Duchenne Muscular Dystrophy (DMD)
Q3
Q2
Q1
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Notice of Proposed Sale of Securities